Instron—USA offers 6800 Series universal testing systems, with capacities ranging from 500 N to 300 kN. These systems deliver exceptional performance while maintaining unrivaled reliability and ...

Plague was already a deadly killer 5,500 years ago, long before cities, farming, or the rat-infested conditions usually linked to historic outbreaks. By analyzing ancient DNA from hunter-gatherer ...

Far removed from its days as a synonym for "huge Class A motorhome," Winnebago is now known for a diverse lineup of on- and off-road RVs of all sizes. Building out its "Backcountry Series," the ...

"We anticipate dosing the first patient in the combination dose expansion cohorts in both early-line MCRPC and metastatic hormone-sensitive prostate cancer over the coming months." (President, CEO & ...

SUNGAI BULOH: Pakatan Harapan vice-president Datuk Seri R Ramanan has denied being involved in a supposed scheme to settle a "corporate mafia" scandal, stating that he does not own any shares in ...

Instron's new Bluehill® 3 Materials Testing software provides a wide range of tailored application modules for all current materials and procedures and enables convenient programming of user- defined ...

Overall survival from the phase 2 trial of abiraterone, olaparib, or abiraterone + olaparib in first-line metastatic castration-resistant prostate cancer (mCRPC) with DNA repair defects (BRCAAway).

Early trials of the drug VIR-5500 showed it shrinking tumours in some patients A new drug for advanced prostate cancer has shown promise in early trials experts have said, with the medication ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Astellas Pharma has agreed to co-develop and co-commercialize Vir Biotechnology’s most advanced immuno-oncology asset, the prostate cancer candidate VIR-5500, through a collaboration that could ...

Astellas is aiding Vir Biotechnology’s oncology pivot with a $1.7 billion global collaboration focused on a potential best-in-class T-cell engager (TCE) for prostate cancer. Under the leadership of ...

The price of gold has surged above $5,500, reflecting a structural erosion of trust in monetary policy, fiscal discipline and US political stability, fund managers say. Central banks’ persistent ...